Early research (Phase 1)Ended earlyNCT03410927
What this trial is testing
TAS0728 in Patients With Solid Tumors With HER2 or HER3 Abnormalities
Who this might be right for
Advanced Solid Tumors With HER2 AbnormalitiesAdvanced Solid Tumors With HER3 Abnormalities
Taiho Oncology, Inc. 19